Fennec Pharmaceuticals Inc

FENC11 Dec 2024
Healthcare
$6.08
+0.01 (+1.32%)
Lowest Today
$6.02
Highest Today
$6.2
Today’s Open
$6.08
Prev. Close
$6.06
52 Week High
$11.92
52 Week Low
$3.96
To Invest in Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc

Healthcare
FENC11 Dec 2024
+0.01 (+1.32%)
1M
3M
6M
1Y
5Y
Low
$6.02
Day’s Range
High
$6.2
6.02
52 Week Low
$3.96
52-Week Range
52 Week High
$11.92
3.96
1 Day
-
1 Week
-
1 month return
+44.54%
3 month return
+16.19%
6 month return
-15.74%
1 Year return
-35.24%
3 Years return
+48.78%
5 Years return
-0.16%
10 Years return
-
Institutional Holdings
Southpoint Capital Advisors LP
14.86
Sonic GP LLC
8.78
Solas Capital Management LLC
7.01
DG Capital Management, LLC
5.55
BlackRock Inc
4.33
Vanguard Group Inc
3.82
Vanguard Total Stock Mkt Idx Inv
3.19

Market Status

Fundamentals
Market Cap
167.93 mln
PB Ratio
57.93
PE Ratio
0
Enterprise Value
162.76 mln
Total Assets
26.86 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Organisation
Fennec Pharmaceuticals Inc
Employees
29
Industry
Biotechnology
CEO
Mr. Rostislav  Raykov
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step